Snowball logo
logo
VRTX_logo

Vertex Pharmaceuticals Incorporated

$516.44-$9.29Β  (1.77%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
7,574.48,930.79,869.211,020.112,074.612,624.3
COGS
904.21,080.31,262.21,530.51,807.11,762.8
Gross Profit
6,670.27,850.48,6079,489.610,267.510,861.5
Operating Expenses & Income
Operating Income
2,782.14,307.43,832(232.9)4,760.74,872
Total Operating Expenses
3,891.23,5434,7759,722.55,506.85,989.9
R&D Expenses
3,051.12,655.83,162.93,630.33,753.73,961.3
Selling General & Admin Expenses
840.1887.21,136.61,464.31,753.11,425.8
Earnings from Continuing Operations
Interest Expense
(61.5)(54.8)(44.1)(30.6)(13.3)(6.6)
Interest Income
4.9144.6614.7598.1490.9362.4
Income Tax Expense
388.3910.4760.2784.1690869.3
Net Income
Net Income
2,342.13,3223,619.6(535.6)3,953.24,405.2
Supplemental
EBIT
2,791.94,287.24,423.9280.54,656.55,281.1
EBITDA
2,917.54,435.54,605.2486.34,863.75,444.5
In millions of USD, except % and values per 1 share